Why the obesity drug market is about to get a lot more crowded
The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
Source: mmm-online.com
Jasper Morley News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jasper Morley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jasper Morley Today - Breaking & Trending Today
THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush
Drugmakers like Novo Nordisk and Amgen are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years.
Source: dailymail.co.uk
FDA awarded record number of review designations to CRISPR drugs in 2023
In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gaining the first FDA approval for a CRISPR-based drug, exagamglogene autotemcel (Casgevy) for the treatment of sickle cell disease with vaso-occlusive crisis.
Source: biopharma-reporter.com
Casgevy approval unlikely to be followed up by another CRISPR drug in near future
Vertex Pharmaceuticals and CRISPR Therapeutics made history last month by gaining approval for the first CRISPR-based drug, Casgevy.
Source: biopharma-reporter.com
GlobalData : Casgevy approval unlikely to be followed up by another CRISPR drug in near future, says GlobalData -December 28, 2023 at 08:29 am EST
28 Dec, 2023 Casgevy approval unlikely to be followed up by another CRISPR drug in near future, says GlobalData Share Print...
Source: marketscreener.com